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The current work was addressed to characterize gallic acid from amla fruit 
and quercetin from peels of pomegranate fruit and formulated into Chitosan 
(CS) nanoparticles and to evaluate their cytotoxicity towards human colorectal 
cancer (HCT 116) cell lines. Identification of the biomolecules was performed by 
chromatographic and spectroscopic techniques and characterization of gallic acid 
and quercetin loaded chitosan nanoparticles carried out by using FT-IR, X- ray 
diffraction, entrapment efficiency and loading content confirmed successful 
encapsulation of biomolecules into nanoparticles. In vitro drug release studies done 
by using simulated fluids at various pH (1.2, 4.5, 7.5, and 7.0) to mimic the GIT tract 
and achieved drug releases 77.56% for gallic acid 79.06% for quercetin at 24 hr. in a 
sustained manner. The human HCT116 cell line by MTT assay results inferred that 
the synthesized CS nanoparticles demonstrated shows more effective antiprolifera-
tive potential with IC50 value of 36.17 ug/ml than polyherbal extract 60.32ug/ml.
Keywords: gallic acid, quercetin, chitosan nanoparticles
1. Introduction
The cancer is one of the most dreaded and threatening diseases in the world, 
causing more than 6 million deaths a year [1]. Colon cancer is recognized as the 
third most common cancer worldwide with high morbidity and mortality, and the 
fourth common cause of death [2]. Various cytotoxic drugs are used for the treat-
ment of colorectal cancer like 5-Fluorouracil, Oxaliplatin and Cisplatin drugs are 
their hydrophobic nature and their susceptibility to develop drug resistance [3, 4].
In these current work great efforts for the discovery and development of nano-
formulation based on natural products on in vitro HCT 116 cell lines study. Here 
gallic acid isolated from amla fruit (Emblica officinalis) and quercetin isolated 
from peels of pomegranate fruit (Punica granatum). Gallic acid is a naturally 
available phenolic compound present in amla fruit which is water insoluble and 
one of the major constituent of amla which might contribute to the health effects 
[5, 6]. Gallic acid exerts an anticarcinogenic activity, antiproliferative and anti-
apoptotic activities against pancreatic cancer cells [7–9]. Flavonoids are a group 
of naturally occurring class of plant secondary metabolites having polyphenolic 
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structure in addition quercetin has anti-tumor properties, anti-inflammatory, 
anti-proliferative, anti-angiogenic [10–15].
There have been particular efforts to evaluate the therapeutic role of these active 
constituents present in plants rather than using whole extracts. The fundamental 
method of reasoning behind these systems contributes greatly to enhance the 
targeting delivery and bioavailability of phenolic and flavonoid remarkable formu-
lation development can be made by preparation of nanotechnology products. The 
eco-friendly synthesis of gallic acid and quercetin loaded chitosan nanoparticles 
(CS nanoparticles) through green route from plant extracts have renowned a wide 
range of application in the field of modern science, due to increased drug efficacy 
and less toxicity in the nanosized mediated drug delivery model. At the same time, 
the use of gallic acid and quercetin in pharmaceutical formulations is limited due 
to its poor water solubility, poor bioavailability and instability in physiological 
medium [16, 17].
Lack of site specificity is one of the major reasons for the drug in reaching the 
target site in therapeutic concentrations in colorectal cancer [18]. Chitosan (CS), 
as the only naturally occurring positive charge polysaccharide, has remarkable 
properties including high bioavailability, super biodegradability, high biocompat-
ibility, non-toxicity etc., On the other hand it causes sustained release of the drug 
from the particle in the tumor environment [19]. The main rationale behind using 
these types of polymers is their ability to prevent drug degradation in the gastric 
environment in the stomach and their ability to release the drug after entering 
the distal ileum [20]. Poloxamer 407 is a hydrophilic nontoxic copolymer used 
for its stabilizing properties and incorporation of hydrophobic drugs capabil-
ity to increase the solubility of biomolecules [21]. Here combined biomolecules 
synergistic activity of nanotechnology approach has been developed to improve 
the bioavailability as to entrap these natural biomolecules into biodegradable 
polymeric CS nanoparticles [22].
The system of glyceryl monooleate (GMO)/chitosan is a surface-modified 
nanoparticulate system consisting of GMO as a lipid portion and chitosan as a 
coating polymer to target colonic area with poloxamer 407 as a stabilizer. Therefore, 
the purpose of this study was to formulate CS nanoparticles of where quercetin 
isolated from peels of pomegranate fruit and gallic acid isolated from amla fruit as a 
model hydrophobic biomolecules followed by lyophilization using probe sonicator 
and High Pressure Homogenization (HPH) method. CS nanoparticles prepared and 
optimized using Quality by design approach by using central composite factorial 
design. Optimized formulation further characterized for different parameters as 
particle size, zeta potential, FT-IR and. Release kinetic studies performed using 
method for conventional nanoparticle release behavior assessment.
In this study, we systematically analyzed the In vitro anti-cancer potential of 
the gallic acid and quercetin loaded chitosan nanoparticles synergy approach for 
combined active biomolecules and compared to their activity to combined extracts 
on HCT 116 human colon cancer cell lines and the mechanism of action of CS 
nanoparticles in regulating the growth of CRC cells. The human HCT116 cell line 
by MTT (3-(4,5-dimethyl-2-tiazolyl)-2,5-diphenyl-2-tetrazolium bromide) assay 
was exposed to cytotoxicity of polyherbal extracts, chitosan nanoparticles and 
cisplatin (Standard) and activity is dependent up to the concentration of 6.25-
100ug/mL for 24 h followed by MTT cellular assays [23]. To determine the poten-
tial anti-cancer effect of, we synthesized CS nanoparticles using gallic acid and 
quercetin biomolecules, which is a phenolic and flavonoid predominantly found in 
amla fruit and peels of pomegranate fruit. HCT116 cells exposed to gallic acid and 
quercetin for 24 h exhibited significant loss of cell viability and proliferation in a 
dose-dependent manner.
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The IC50 of polyherbal extract, chitosan nanoparticles and standard cisplatin 
after 48 h treatment it was found to be 60.32 and 36.17 and 8.915 ug/ml respectively. 
The obtained result inferred that the synthesized CS nanoparticles demonstrated 
shows more effective antiproliferative potential on HCT-116cell lines with IC50 value 
of 36.17 ug/ml than polyherbal extract 60.32 ug/ml were discussed briefly in this 
manuscript.
2. Materials and methods
2.1 Materials
Poloxamer 407 from BASF, Chitosan 90% dda obtained from CIFT Cochin, GMO 
from Mohini organics, standard gallic acid and quercetin purchased from Loba 
Chemie., 10% fetal bovine serum (Invitrogen Life Technologies USA). RPMI 1640 
and McCoy’s 5A medium (Fisher Scientific, Waltham, USA). All the solvents and 
chemicals used were procured from Himedia Laboratories, Research Lab. Mumbai.
2.2 Plant material
The sample of different parts of plant of amla and pomegranate was col-
lected from Kolhapur district and was authenticated by Dr. Madhukar Bachulkar, 
Principal, Arts and Science College Peth Vadagaon Kolhapur. The voucher her-
barium (PSP-1 and 2) has been deposited in the department of Pharmacognosy 
Bharati Vidyapeeth College of Pharmacy, Kolhapur. Amla fruit and peels of pome-
granate fruit were collected in season (Feb-March), were dried under shade for 
10–15 days in air.
2.3 Soxhlet extraction method
In order to extract Flavonoid and phenolics from plants with a high degree of 
accuracy, various solvents of differing polarities were tried as chloroform, ethanol 
and ethyl acetate. The dried powder of amla fruit and peels of pomegranate powder 
extracted with 800 ml in various solvents for 6 hours separately. All extracts were 
filtered and evaporated to dryness under reduced pressure at 60 °C by a rotary 
evaporator and to determine percentage yield for all three different solvents [24].
2.4 Phytochemical screening
2.4.1 Qualitative test
Phytochemical analysis was carried out to detect the presence of primary and 
secondary metabolites were used to identify the biomolecules present in the plant 
extract [25]. The phytochemical tests carried out for amla and peels of pomegran-
ate extract include alkaloids, glycosides, saponins, tannins, triterpenoids, steroid, 
flavonoids and carbohydrate [26].
2.4.2 Quantitative tests
2.4.2.1 Determination of total phenolic content for amla extract
Phenolic compounds are important plant constituents with redox properties 
responsible for antioxidant activity. Folin–Ciocalteu’s method (FC) is a colorimetric 
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method based on transfer of electrons between reagents and polyphenols. Different 
solvent extract chloroform, ethanol and ethyl acetate of amla fruit used for deter-
mination of phenolic content. The reaction mixture was prepared by mixing 1 ml 
of methanolic solution of all extracts, 2.5 ml of 10% Folin–Ciocalteu’s reagent 
dissolved in water and 2.5 ml 7.5% NaHCO3. Blank was concomitantly prepared, 
containing 0.5 ml methanol, 2.5 ml 10% Folin–Ciocalteu’s reagent dissolved in 
water and 2.5 ml of 7.5% of NaHCO3. The samples were thereafter incubated in a 
thermostat at 45o C for 45 min. The same procedure was repeated for the standard 
solution of gallic acid (Standard) in methanol (10to100μg/ml) and for blank then 
calibration line was construed and absorbance measured at λmax 765 nm [27]. The 
samples were prepared in triplicate for each analysis and the mean value of absor-
bance was obtained.
2.4.2.2 Determination of total flavonoid content for pomegranate peel extract
Flavonoids are group of polyphenolic compound used for different activities 
and their potency depends on the number and position of free hydroxy groups. As 
a basis quantitative determination, flavonoid contents in pomegranate peel extract 
were determined using aluminum chloride colorimetric method with sufficient 
modification. In this process, flavonoid content was determined using quercetin 
standard (5 to 320 μg/mL) to make the calibration curve. Different solvent extracts 
chloroform, ethanol and ethyl acetate of pomegranate peel used for determination 
of flavonoid content. All procedure followed for preparation of different extracts of 
sample solution, blank and for standard and their corresponding absorbances were 
measured at 415 nm with a UV-1800 spectrophotometer [28].
3.  Techniques of isolation and purification of bioactive molecules  
from extracts
3.1 Fractionation of bioactive compound by flash chromatographic technique
Flash chromatography instrument consisting of (Analytical technologies 
limited, Shanghai china) consisting of TBP2H02pump along with TBD2000 UV 
detector and automatic fraction collector was used for analysis. System equipped 
with Chromo station software was used for data monitoring during the analysis. 
The separation was carried out on OROCHEM OROFLO-4SiHPS column made up 
of silica particles [29, 30].
3.2 Gas chromatography
The gas chromatography used for estimation of residual class 3 ethyl acetate 
solvent in both crude extracts was performed using a Gas Chromatography system 
7890 B with Agilent DB 624 column with helium gas at 1 ml/min flow mode refer-
ence solution tetrahydrofuran. GC temperature was set at 50 °C (hold for couple of 
min) to 250 °C at 20 °C/min. (hold up to 5 min) [31, 32].
4. Structural clarification of the bioactive molecules
The flash chromatographic fractions of amla fraction no FA004 and pomegranate 
fraction no FP004 were filtered, dried and kept at 4 ° C for characterization of FT-IR 
and 1H-NMR techniques and quantitavely estimated by HPLC technique [33, 34].
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4.1 FTIR spectroscopy
FTIR has proven to be a valuable tool for the characterization and identification 
of functional groups present in compound from plants extract. Infrared spectra 
was collected using IR (α-ATR Bruker Germany spectrometer) operated form 
4000–600 cm−1 at resolution of 4 cm−1. Data analyzed using Opus software.
4.2 NMR spectroscopy of the isolated compound
Only fraction A16 and Fraction P4 was additionally elucidated by 1HNMR by 
using solvent D6 + CDCL3 MIX. The analysis was done at the BRUKER instrument 
of 400 MHz [35].
4.3 HPLC of isolated compounds
HPLC PU-2080 Plus (Systronics) with UV-2075 plus intelligent detector and 
HPLC C18 column (250 × 4.6 mm, 5 μm) was set at 270 nm for estimation of gal-
lic acid and 259 nm for estimation of quercetin [36, 37]. HPLC PU-2080 Plus 
(Systronics) with UV-2075 plus intelligent detector and HPLC C18 column (250 × 4.6 
mm, 5 μm) was set at 270 nm for estimation of gallic acid and 259 nm for estimation 
of quercetin. The mobile phase Acetonitrile and 2% Acetic Acid with ratio 40:60 
used for elution of both compounds. Flow of mobile phase and injection loop was set 
at 1.0 ml/min and 20 μL respectively. Quantitative determination of gallic acid and 
quercetin content in fraction concentrations (FA004 by flash chromatography of amla 
extract) in the range 0.01 to 0.5 mg/ml and (Fraction FP004 by flash chromatography 
of pomegranate extract) in the concentration range of 0.01 to 0.5 μg/ml used.
5. Determination of solubility of isolated compound
The two isolated compounds were analyzed for their solubility in different 
solvents as in DMSO, ethanol, methanol and acetone.
6. Melting point determination
Melting points of two isolated biomolecule compounds was done in thermonic 
apparatus to determine its identity and purity. The observed melting point of 
isolated compound was compared with the standard melting point of respective 
gallic acid and quercetin.
7. Antioxidant activity by DPPH method
2, 2-diphenyl-1-picryl-hydrazyl (DPPH) is a stable organic free radical used to esti-
mate the antioxidant activity of various compounds. The scavenging action on DPPH 
radical from amla fruit and isolated fraction (FA004 by flash chromatography) and 
peels of pomegranate extract and isolated fraction (FP004 by flash chromatography of 
peels of pomegranate extract) determined by following method [38, 39]. As of different 
concentrations was mixed with an aliquot of DPPH (1 ml, 0.004% w/v) and analyzed 
at 517 nm. Then the scavenging capacity was calculated using equation number (1).
 ( )
( )A517 of control – A517 of sample







8. Formulation of nanoparticles
An o/w nanoemulsion of gallic acid and quercetin was prepared by using a 
GMO/chitosan framework as reported by with slight modifications. Briefly, isolated 
gallic acid (100 mg) and quercetin (100 mg) were dissolved in molten GMO (2 g), 
then add 12.5 ml of 0.1% poloxamer 407 sonicated at 18 W for 3 min in probe soni-
cator. To this emulsion, dropwise 12.5 ml of 2.4% chitosan solution was added again 
using probe sonicator at 16 W for 4 min [40, 41]. Finally this phase was subjected 
to twelve cycles of HPH at 15,000 psi to give the nanoemulsion. Then, lyophilized 
with 2% mannitol as a cryoprotectant for 48 hr. Central composite design [42] was 
applied to examine the combined effect two variables, each at 2 levels and the pos-
sible 9 combinations of CS nanoparticles.
9. Characterization of polyherbal nanoparticles
9.1 Particle size and zeta potential
Average particle size and zeta potential of the CS nanoparticles were deter-
mined by Particle Size Analyzer (Zetasizer Ver System; Malvern Instruments Ltd., 
Malvern, UK). To analyze particle size, nanosuspension was diluted with filtered 
(0.22 lm) ultra pure water [43–45].
9.2 By FTIR spectroscopy
FTIR has proven to be a valuable tool for identification of functional groups 
present in compound from plants. Attenuated total reflection/Fourier transform 
infrared spectroscopic (ATR/FTIR) spectra was collected at room temperature by 
coupling ATR accessory to an FTIR spectrometer (Perkin Elmer, Spectrum 100).
9.3 In vitro release studies
CS nanoparticles were tested in various simulated fluids at different pH to 
evaluate the release of nanoparticles at particular pH and also to determine the 
drug release [46]. Four milligrams of CS nanoparticles were dispersed in a freshly 
prepared phosphate-buffered saline (PBS; pH = 2.0, 4.5, 6.8, 7.4) as a release 
medium in a dialysis membrane sac (mw cut-off 12 kDa; Sigma Aldrich) to simulate 
ileo-colon conditions for 24 hr [47]. The enclosed dialysis sac was immersed in a 
beaker containing 50 mL of the release medium. The beaker was placed in a shaking 
incubator at 37 °C under mild agitation (90–100 rpm) PBS; pH = 2.0 for first four 
hour, pH = 4.5 for next five to nine hour, pH = 6.8 for next ten to thirteen hour and 
finally pH = 7.4 for fourteen to twenty-four hour. The supernatant 5 ml withdrawn 
at specified time intervals and assayed for drug release in UV spectrophotometri-
cally gallic acid at 270 nm and quercetin at 259 nm.
10. In vitro anticancer activity (cytotoxicity) by MTT assay
10.1 Cell culture
A human colorectal adenocarcinoma cell line (HCT116) were cultured with RPMI 
1640 and McCoy’s 5A medium (Fisher Scientific, Waltham, MA, USA), respectively 
[48]. All cell culture mediums contained 10% fetal bovine serum. Cells were incubated 
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in a CO2 incubator at 37 °C with 5% CO2. After reaching confluency, cells were isolated 
from the dish with Trypsin–EDTA. The cell suspension was centrifuged at 1000 r/min 
for 5 min and then re-suspended in growth medium for further experiments.
10.2 Cell viability assay
Cell viability was studied using an MTT assay. Cells were grown in a medium 
containing 10% FBS, seeded in 96-well plates at a density of 2x105 cells/well, and 
incubated at 37 °C in CO2 incubator with 5% CO2 for 24 h [49]. Then, polyherbal 
extract, CS nanoparticles and standard cisplatin were added (final concentrations 
of 6.25, 12.5, 25, 50, and 100 ug/ml) to the mono-layers of cells, which were sub-
sequently incubated for at 24 and 48 h, media were aspirated and MTT solution at 
a concentration of 5 mg/ml in phosphate-buffered saline (PBS) buffer was added 
20 ml/well. After further incubation (3 h), the media was removed and replaced with 
100 ml of DMSO. Plates were washed with 1% acetic acid, air-dried, and then 10 mM 
Tris base pH 7.4 (150 μl) was added to the wells to solubilize the dye. The plates 
were shaken vigorously for 5 min and color absorbance was measured at 540 nm 
using an ELISA microplate reader. (ELISA reader Denver Jasco Model 7800 UV/VIS 
Spectrophotometer Jasco Tokyo, Japan) Untreated cells were used as positive controls 
with 100% viability and cells without assay reagents were used as a blank.
11. Result and discussion
11.1 Soxhlet extraction method
Soxhlet extraction method carried out for extraction of amla fruit and peels of 
pomegranate fruit by using three solvents as chloroform, ethanol and ethyl acetate 
separately. Ethyl acetate solvent gives highest yield 42.51% (Amla fruit) and 42.89% 
(Pomegranate peels) hence used for extraction of phenolics and flavonoids [50].
11.2 Phytochemical screening
11.2.1 Qualitative tests
Qualitative tests of Phytochemical screening of amla fruit and pomegranate 
peel extract gives positive test for presence of flavonoids, alkaloids, tannins and 
carbohydrate.
11.2.2 Quantitative test
11.2.2.1 Total phenolic content
Calibration curve of standard gallic acid showed linear equation at y = 0.014x + 
0.395, R2 = 0.996 The content of phenolics in different solvents was as 25.73 ± 0.21, 
42.09 ± 0.19 and 63.76 ± 0.29 mg GAE/g for chloroform, ethanol and ethyl acetate 
respectively. As compare to other solvent ethyl acetate gave more yields hence this is 
suitable solvent for extraction of phenolics.
11.2.2.2 Total flavonoid content
The concentration of flavonoid standard quercetin on the calibration line was 
based on the calculated absorbance at y = 0.017 × +0.412, R2 = 0.990 (Figure 1) 
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then, the content of flavonoids in pomegranate peels of different solvent extract was 
expressed in terms as mg QE/g. The content of flavonoid in different solvents was 
as 32.88 ± 0.26, 42.11 ± 0.29 and 70.8 ± 0.1732 mg QE/g for chloroform, ethanol and 
ethyl acetate respectively. As compare to other solvents ethyl acetate gave more yields.
11.3  Techniques of isolation and purification of bioactive molecule  
from amla fruit and pomegranate peel extract
11.3.1 Fractionation of bioactive compound by flash chromatographic technique
The mobile phase used as ethyl acetate: methanol 100:0 to 0:100 with flow rates 
were kept at 4 ml/min with wavelength for amla fruit at 270 nm and pomegranate 
peel extract at 263.5 nm. Column was loaded with 8.0 gm slurry (3 g extract +5 g 
silica gel) in 25 gm of silica gel (200–400 mesh size).
1 gm of amla extract and peels of pomegranate powder extract separately mixed 
with 3 gm of silica gel and triturated properly in mortar and pestle. Then, properly 
mixed extract samples were loaded in sample holder. The separation was completed 
in 15 minutes only. The Five fractions were isolated by linear gradient with peak 
tube volume was 14 ml and run time was 15 min. Different fractions no. FA001 to 
FA005 from amla extract and FP001 to FP005 from peels of pomegranate extract 
were isolated and dried on buchi roto evaporator (R-210 water bath B-491) for 
dryness.
Among all five fractions of amla extract fraction number the UV spectra of 
fraction no FA004 phytoconstituent which gives absorbance at 270.5 nm and 
this absorbance confirmed with standard gallic acid solution spectra at 272 nm. 
(Figure 2A) The percentage yield of fraction FA004 was found to be 33.4 mg/
gm. The five fractions of peels of pomegranate extract fraction no FB004 gives 
maximum absorbance at 263.5 nm and also this absorbance confirmed by stan-
dard quercetin sample absorbance at 345 nm (Figure 2B) scanning with UV 
Spectrophotometry summarized in Tables 1 and 2 . The percentage yield of 
fraction FP004 was found to be 42.6 mg/gm. Further these two isolated fractions 
no FA004 and FP004 characterized for IR, H1NMR, HPLC and HPTLC techniques 
for better results.
11.3.2 Gas chromatography
The study represented a simple gas chromatographic method for estimation of ethyl 
acetate contents in both amla and pomegranate extract. The GC analysis of the crude 
Figure 1. 
IR spectra of isolate of [A] Amla fruit [B] pomegranate peel extract.
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Peak Start (nm) Apex (nm) End (nm) Height (Abs) Area
FA001 600.0 430.5 379.0 0.039 1.257
FA002 379.0 350.5 340.5 0.144 2.708
FA003 340.5 339.5 304.0 0.154 3.471
FA004 304.0 270.5 262.0 0.426 11.114
FA005 262.0 239.0 210.0 1.971 70.223
Table 1. 
Flash chromatography of amla extract.
Peak Start (nm) Apex (nm) End (nm) Height (Abs) Area
FP001 600.0 429.5 379.0 0.064 2.745
FP002 379.0 350.0 340.5 0.266 5.440
FP003 340.5 335.0 302.5 0.272 5.920
FP004 302.0 263.5 252.0 0.369 12.189
FP005 252.0 230.5 210.0 1.893 53.258
Table 2. 
Flash chromatography of peels of pomegranate extract.
Figure 2. 
Flash chromatogram of [A] Amla fruit [B] pomegranate peel extract.
Figure 3. 
Gas chromatogram of [A] Amla fruit [B] pomegranate peel extract.
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ethyl acetate extracts of amla gives retention time at 4.526 min (Figure 3A) and for 
pomegranate fruit at 4.528 min. (Figure 3B) Ethyl acetate concentration in amla fruit 
was found to be 1305.376 ppm and in pomegranate fruit was found to be 1538.440 ppm. 
Excellent results were obtained within the worldwide accepted validation reference val-
ues and particularly taking into account the low concentration levels investigated [51].
11.4 Structural clarification of the bioactive molecules
The isolated compounds (Fraction No. FA004 from amla extract and FP004 
from peels of pomegranate extract by flash chromatography) was characterized by 
using FT-IR, 1H-NMR and quantitatively estimated by using HPLC technique [52].
11.4.1 FTIR spectroscopy of the isolated compound
FT-IR spectra of isolate of amla fruit extract resulted in presence of functional 
groups hydroxyl (-OH) stretch, C-H stretch of alkenes, C=O stretch for acid and 
aromatic benzonoid ring (Figure 1A) and FT-IR spectra of isolate of Pomegranate 
peel extract resulted in presence of functional groups hydroxyl (-OH) stretch at 
3366 cm−1, C-H stretch of alkenes at 2945 cm−1, C=O stretch for lactone and aro-
matic benzonoid ring 1020 cm−1 (Figure 3).
11.4.2 NMR spectroscopy of the isolated compound
The analysis was done at the BRUKER instrument of 400 MHz d 9.136  
(1H, H-7, s), 7.08 (1H, H-2, H-6, s) and 5.011 (1H, H-3, H-4, H-5, s). 1H NMR 
of isolate of amla fruit showed the aromatic proton, acidic proton and hydroxyl 
proton and presence of 7 carbons in structure (Figure 4A) given molecular formula 
as C7H6O5 [53] 
1H-NMR signals of isolate of Pomegranate peel extract shows signals 
at 12 (S 1H OH Pyran), 6.2 (S 2H Aromatic OH), 6.9 (S1H Aromatic OH), 7.1 (S1H 
Aromatic OH), 7–8 (S Aromatic proton) 1H NMR showed the aromatic proton 
and hydroxyl proton and presence of 15 carbons (Figure 4B) in structure given 
molecular formula as C15H10O7.
Figure 4. 
NMR spectra of isolated compound and structure of compounds [A] Amla fruit (Gallic acid) [B] pomegranate 
peel extract (quercetin).
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11.4.3 HPLC analysis of isolated compounds
A comparison between the spectra of fruits of amla extract (Fraction no A004 
by flash chromatography) peak at 3.165 min confirmed with that of standard gallic 
acid peak at 3.207 min respectively (Figure 5A and B). A good linearity was found 
from 5–15 μg/mL gallic acid, and the linear regression equation was y = 8008x-397.0 
(rc = 0.999) where y is the peak height. The gallic acid from amla fruit extract was 
fractionated by HPLC of which 27.15 ± 0.001 μg/mg GAE equivalent by HPLC 
method were characterized.
Same comparison between the spectra of peels of pomegranate (Fraction 
no B004 by flash chromatography) peak at 5.242 min with that of standard 
quercetin confirmed that the retention time of the analyte was 5.248 min 
respectively (Figure 6A and B). Linearity for the developed method was found 
over the concentration range 3–18 μg/ml with a linear regression equation was 
y = 16.01x + 25628 where y is the peak height correlation coefficient of 0.999.
11.5. Antioxidant activity
11.5.1 Antioxidant activity by DPPH method
The DPPH is a stable free radical, which has been widely accepted as a tool for 
estimating free radical-scavenging activities of antioxidants. The scavenging activ-
ity on 2, 2-diphenyl-1-picryl-hydrazyl (DPPH) radical of both the fruits extract 
and isolated fractions was determined by following method. The extracts of differ-
ent concentrations were mixed with an aliquot of DPPH (1 ml, 0.004% w/v) [54].  
Figure 5. 
Chromatogram of [A] standard Gallic acid [B] isolated fraction of amla extract.
Figure 6. 
Chromatogram of [A] standard quercetin [B] isolated fraction of pomegranate peel extract.
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The mixtures were vigorously shaken and left to stand for 30 min in the dark at 
room temperature. For this method the absorbance were recorded at 517 nm. The 
percentages of remaining DPPH in the presence of the amla and pomegranate peel 
extract (Figures 7 and 8) and its fractions at different concentrations are shown in 
Table 3.
Figure 7. 
DPPH radial scavenging activity (A) Amla extract (B) isolated fraction of FA004 by flash chromatography.
Figure 8. 
DPPH radial scavenging activity (A) peels of pomegranate extract (B) isolated fraction no FP004 by flash 
chromatography.
Sample R2 IC50
Ascorbic acid (Standard) 0.996 8.98 μg/ml
Amla extract 0.884 25.74 μg/ml
Isolated Fraction [FA004] 0.904 14.44 μg/ml
Pomegranate peel extract 0.863 29.89 μg/ml
Isolated Fraction [FP004] 0.910 11.21 μg/ml
Table 3. 
Antioxidant activity of amla and pomegranate extract by DPPH.
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11.6 Determination of solubility of isolated compound
The isolated compound was analyzed for their solubility in different solvents. 
White colored powder of amla extract (FA004 Flash chromatography) which is 
soluble in ether, ethanol, methanol, glycerol and acetone. Yellow colored crystal-
line powder of pomegranate extract (FP004 Flash chromatography) practically 
insoluble in water and soluble in DMSO, ethanol, methanol and acetone.
11.7 Melting point determination
Melting point of compound was done in thermonic apparatus to determine 
its identity and purity. The observed melting point of isolated compound of amla 
extract (FA004 Flash chromatography) was 255–257 ° C compared with the stan-
dard melting point (260 °C) of respective isolated gallic acid. The observed melting 
point of isolated compound of pomegranate extract (FP004 Flash chromatography) 
was 313–316 °C compared with the standard melting point (316 °C) of respective 
isolated quercetin.
11.8 Formulation of CS nanoparticles
In this study the goals for optimization were to minimizing particle size and 
maximum Zeta potential. Desirability ramp showing optimum conditions to 
formulate CS nanoparticles as chitosan 2.4%, and Poloxamer (407) 0.1% to achieve 
particle size 218.33 nm and zeta potential11.50 mV with desirability 1.000.
11.9 Characterization of CS nanoparticles
11.9.1 Analysis of particle size and zeta potential
A mean diameter of particle size of CS nanoparticles was found to be 214.2 ± 
1.28 nm with +14.7 mV zeta potential [14, 55, 56]. Chitosan on the other hand has a 
positive charge in acidic solutions due to the presence of protonated amino groups 
which was appropriate adhere negatively charged intestinal mucus layer. This 
explains that outer coating of nanoparticles was CS only.
11.9.2 FTIR of CS nanoparticles
The characteristic groups of chitosan at (Figure 9A) 3285.15 cm−1 for O-H 
stretching 2875.66 cm−1 for C-H stretching and 1415.23 cm−1 for amide C-N stretch-
ing. The bands at 1150.54 cm−1 for asymmetric stretching of the bond C-O-C 
and 1062.04 and 1023.35 cm−1 for vibrations involving the C-O bonds of primary 
alcohols [57]. The carbon chain of poloxamer 407 (Figure 9B) at 2881.11 cm−1 
aliphatic C-H stretching, plane O-H bend at 1365.12 cm−1 and 1242.02 cm−1, C-O 
stretch at 1096.99 cm−1, CH=CR2 at 840.46 cm
−1. The C=O functionality of GMO 
(Figure 9C) was seen with a strong peak at 1738 cm−1. In the spectrum of gallic 
acid (Figure 9D) there is a broad band at 3194.61 cm−1 related to OH stretching 
and hydrogen bonds between phenolic hydroxyl groups. The COOH stretch/bend 
is observed at 1255.93 cm−1 Aromatic ring stretching is observed at 1454.44 cm−1 
[58]. C- O stretching is at 1021.45 cm−1 In the spectrum of quercetin (Figure 9E) 
there is a broad band at 3194.61 cm−1 related to OH stretching and hydrogen bonds 
between phenolic hydroxyl groups. O-H stretch at 3190.38 cm−1, =C-H stretch at 




IR spectra of CS nanoparticles (a) chitosan (B) Poloxamer 407 (C) GMO (D) quercetin (E) Gallic acid (E) 
CS nanoparticles.
1145.06 cm−1. The COOH stretch/bend is observed at 1255.93 cm−1 The spectra of 
the gallic acid and quercetin loaded CS nanoparticles showed that O-H stretch of 
gallic acid and quercetin was disappeared (Figure 9F). Here all data of FTIR results 
conclude that encapsulation of gallic acid and quercetin into CS nanoparticles with 
intermolecular hydrogen bonding occurred in the nanoformulation which corre-
lated with the less crystalline compared to both pure biomolecules.
11.9.3 In vitro release studies
As a result CS nanoparticles have indicated improved drug releases 77.56% for 
gallic acid 79.06% for quercetin at 24 hr. respectively. So the CS nanoparticles can 
be considered as a potential barrier, which can release the biomolecules at colonic 
pH [59]. By engineering chitosan approach gallic acid and quercetin biomolecules 
achieved sustained and controlled release and also benefitted by its targeting 
property to colonic region. To describe the mechanism of gallic acid and quercetin 
release from the CS nanoparticles, [60] the data was plotted into a few kinetic 
models and best fitted information into the Korsmeyer–Peppas power law model.
11.10 Methods of anticancer activity determination
11.10.1 In vitro cytotoxicity by MTT assay
After 24 hours of incubation, cell viability was determined by the MTT assay. 
The nanoparticles induced cell cytotoxicity in a concentration dependent manner, 
as illustrated. Cytotoxicity of polyherbal extracts, CS nanoparticles and cisplatin 
(Standard) was dose on HCT 116 cell lines and activity is dependent up to the con-
centration of 6.25–100 ug/mL. The IC50 of polyherbal extract, chitosan nanopar-
ticles and standard after 48 h treatment it was found to be 60.32 and 36.17 and 8.915 
ug/ml respectively summarized in Table 4.
The antiproliferative potential of all samples shown as cytotoxicity of  
standard cisplatin (Figure 10A) CS nanoparticles (Figure 10B) polyherbal extract 
(Figure 10C) was done on HCT 116 cell lines and activity is dependent up to the 
concentration of 6.25–100 ug/mL. MTT assay determined the cytotoxic effect 
of all samples by decreasing the cell viability of HCT116 colon cancer cells with 
different serial dilutions. The half maximal inhibitory concentration (IC50) 
was evaluated to determine the effectiveness of CS nanoparticles in inhibiting 
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Name of Samples Concentrations ug/ml
Untreated 6.25 12.5 25 50 100
Standard (A) 1.157 0.680 0.582 0.19 0.0885 0.06
IC50 = 10.55 ug/ml
Polyherbal extract (B) 1.157 1.677 1.301 0.794 0.478 0.182
IC50 = 60.32 ug/ml
CS nanoparticles (C) 1.157 0.906 0.892 0.79 0.141 0.028
IC50 = 36.173 ug/ml
Table 4. 
MTT data analysis of HCT-116 cell lines.
Figure 10. 
Concentrations used for MTT assay (A) standard (cisplatin) (B) Polyherbal extract (C) CS nanoparticles.
Figure 11. 
Microscopy imaging of cellular uptakes (A) standard (B) CS nanoparticles (C) Polyherbal extract  
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biological or biochemical functions. CS nanoparticles shows a higher cytotoxic 
effect on HCT116 cells with low concentrations (IC50 = 36.173 μg/ml) than poly-
herbal extract (IC50 = 60.32 μg/ml) that might be due to the active biomolecules 
capped to the nanoparticles.
HCT 116 cell lines considered to have more prominent take-up for CS nanopar-
ticles and more stable even at low concentrations and longer interval than poly-
herbal extract. Microscopy imaging of cellular uptakes shows as standard cisplatin 
(Figure 11A) CS nanoparticles (Figure 11B) polyherbal extract (Figure 11C) and 
untreated HCT116 cell lines (Figure 11D) HCT 116 cell lines subjectively were 
deemed to have had greater uptake for CS nanoparticles and more stable even at 
low concentrations than polyherbal extract expected to be longer interval than 
polyherbal extract.
12. Conclusion
In conclusion, the presence of phenolic compound (gallic acid) and flavonoid 
(quercetin) could be one of the contributing factors for mechanism of in vitro stud-
ies on HCT 116 cell lines. Model hydrophobic biomolecules with nanoparticle size 
range, positive charge on particle with good value and sustained in-vitro releases of 
gallic acid and quercetin especially in wide pH range of entire gastrointestinal tract 
from nanoparticles were special findings associated with colonic site. Therefore, 
discovery and development of new nanoformulation based on natural products 
have been the reported to have a controlled effect on cancer cell lines; therefore, 
they have the potential to be used as an important therapeutic anticancer biomol-
ecules. Further studies are warranted to decipher the probable mechanism by which 
gallic acid and quercetin nanoparticles exert anticancer effect.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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